Growing Awareness for Animal Welfare and Increasing Demand for Dairy and Beef Products to Drive Cow Lifting Harness Market Growth from 2023 to 2033

Cow lifting harness market is anticipated to be valued $338 million in 2023, growing to $520 million by 2033. Demand is estimated to expand at a CAGR of 4.4% over the forecast period. The formation of several animal welfare organisations, such as Global Animal Protection, is expected to increase demand for cow lifting harness. The …

Research and Development for Hutchinson Gilford progeria syndrome to Register 8.5% CAGR | FMI Study

During the forecast period 2023 to 2033, the Hutchinson Gilford progeria syndrome market is expected to grow at a value of 8.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Hutchinson Gilford progeria syndrome is expected to rise up to a market valuation of US$ 15,990 Million. Around 400 …

Thrombocytopenia Treatment Market Value to reach US$ 10 Billion by 2033, expected to surge at over 5% CAGR | FMI Report

A recently published study by FMI expects the global thrombocytopenia treatment market to augment at a 5.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 10 Billion is expected for the market. The thrombocytopenia treatment market is predicted to increase significantly, since patients with thrombocytopenia experience …

Global Marburg Virus Disease Therapeutics Market to surge at a 5.5% CAGR until 2033, reaching US$ 155 Million | FMI Report

During the forecast period 2023 to 2033, the Marburg virus disease therapeutics market is expected to grow at a value of 5.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Marburg virus disease therapeutics is expected to rise up to a market valuation of US$ 155 Million. Growth of …

Oral segment constitutes the bulk of 45% in the Babesiosis Treatment Market in 2023, FMI Report

In 2023, the market for babesiosis treatments is projected to be worth US$1.21 billion. The overall market for babesiosis treatment is anticipated to grow at a CAGR of 5.0% between 2023 and 2033, reaching a value of approximately US$ 1.98 Billion by 2033 due to ongoing advancements in pharmaceuticals and biotechnology for the treatment of …

Aarskog Scott syndrome treatment Market Expected to Register 6.5% CAGR in the forecast period 2023 to 2033 | FMI Study

During the forecast period 2023 to 2033, the Aarskog Scott syndrome treatment market is expected to grow at a value of 6.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Aarskog Scott syndrome treatment is expected to rise up to a market valuation of US$ 6 Billion. Ongoing clinical …

Vein Finder Market is expected to reach US$ 86.8 Million by 2028, at a CAGR 10.9%

Advancements in healthcare technology have fuelled a spate of innovations in medical devices, with top-of-the-line product launches presenting enhanced device functionalities. The global Vein Finder Market is anticipated to reach US$ 86.8 Million by 2028, from $42.1 Million in 2021. Throughout the forecast period, the market is expected to increase at a CAGR of 10.9%. …

Generic Oncology Drugs Market is expected to reach US$ 34.8 billion by 2028, at a CAGR 6%

The global generic oncology drugs market size was valued at US$ 24.5 billion in 2022 and is expected to grow at a 6% CAGR between 2022 and 2028, reaching more than US$ 34.8 billion by the end of 2028. Increasing inclination of individuals towards smoking and tobacco consumption is the chief cause of cancer. Secondary …

Smart Pill Boxes and Bottles Market is anticipated to reach US$ 388.2 Million by 2033

The global market for smart pill boxes and bottles was valued at $144.2 million in 2022 and is estimated to reach 160.2 million in 2023. The market for smart pill boxes and bottles is predicted to grow at a 9.3% CAGR between 2023 and 2033, reaching US$ 388.2 million by the end of 2033. Medication …

Home Healthcare Market is predicted to record a 3.1% CAGR through 2033

The home healthcare market is projected to secure a valuation of US$ 3.2 billion in 2023 and is estimated to grow at US$ 4.4 billion by 2033. The market is predicted to record a CAGR of 3.1% during the forecast period. The increasing demand for home healthcare, surging chronic patients, complex medication, and old aged population are driving …